Mird-226 [top] 🎁 Must Watch

The pamphlet includes a wide array of radiopharmaceuticals used in both diagnostic and therapeutic settings. For each, it provides detailed biokinetic data that can be used to tailor radiation dose calculations to individual patient needs and characteristics.

April 16, 2026 Prepared For: General Technical Audience MIRD-226

MIRD-226 presents state-of-the-art biokinetic models reflecting current understanding of how radiopharmaceuticals behave within the human body. These models account for the absorption, distribution, metabolism, and excretion (ADME) of radiopharmaceuticals, offering more precise dosimetry estimates. The pamphlet includes a wide array of radiopharmaceuticals